Tumour conference simulation for surgeons

HCC and liver metastases

Course objective:
This course focusses on the role of liver surgery in the context of advanced tumour diseases. Due to modern surgical and radiological interventional procedures (volume-hypertrophy by PVE or SIRT), even patients with advanced hepatic tumour disease can be treated interventionally. Today, the optimal individual and usually multi-modal therapy plan is often determined in interdisciplinary tumour conferences. Therapy decisions should be made based on the current best evidence in surgical procedures (minimally invasive liver surgery, two-stage resection, ALPPS, liver-first approach), adjuvant and neo-adjuvant chemotherapy concepts and locally ablative procedures (radio frequency ablation, SIRT, TACE, etc.).
This course presents multi-modal therapy concepts for primary and secondary liver tumours as well as current best evidence. These concepts will be applied by participants in an interactive simulation of an interdisciplinary tumour experts’ conference using a broad range of case examples. Performance tests at the end of each session will help participants to monitor their own learning process.



Availability:

Maximum number of participants: 10-15



Target groups:

Liver surgeons and surgical oncologists



Course evaluation:

The participants emphasized that this workshop puts perfect focus on relevant facts.

Duration:
1 – 1,5 days



Venue:

Any conference room.

An online version of this workshop is also perfectly applicable.



Content:

Day 1:
Hepatocellular carcinoma
Introduction into the interdisciplinarity in HCC management
HCC treatment per guidelines (hepatologist)
Surgery on patients with BCLC 0 and A (surgeon)
RFA on patients with BCLC 0 and A (radiologist)
Case discussion: ablation versus resection versus combination therapy, therapy concepts beyond the classical guidelines
Evidence of SIRT and difference to TACE (radiologist)
Surgery on patients with BCLC B (surgeon)
Case discussion: SIRT for induction of the volume hypertrophy
Liver function: what the practitioner needs to know (hepatologist)
Interactive case discussion and tumour conference simulation

Day 2:
Metastasising colorectal carcinoma

Introduction into the systemic and personalised treatment of CRC (oncologist)
Expanding the limits of surgery and local therapy: Procedure for liver hypertrophy induction (surgeon)
Ablation of liver metastases (radiologist)
Case discussion: RFA versus resection versus combination therapy
SIRT for „liver-only“ mCRC: arguments from the oncologist’s point of view (oncologist and surgeon)
Interactive case discussion and tumour conference simulation

Neuroendocrine carcinomas

ENETS guidelines 2016: what is new? (endocrinologist)
Evidence of SIRT for NET and difference to TACE (oncologist)
Minimally invasive surgery for metastasising NET? (surgeon)
Interactive case discussion and tumour conference simulation

Interdisciplinary clinical management of SIRT patients

Management of SIRT patients: (surgeon)
– before the intervention: preparation, clinical parameters for determining the indication
– after the intervention: monitoring, follow-up care
Prevention, recognition and management of interventional complications (radiologist)

Registration is compulsory. Cancellations received up to two weeks prior to the event date will be charged with a processing fee of 25,- Euros. After this date or in case of non-attendance, we will charge the entire conference fee. Registration as well as cancellation must be in writing. You have general questions or booking requests?

contact us